Dr Min Yeo

29/05/2026

29/05/2026

In a new blog post, Dr. Michelle Kittleson writes that clinical decisions should be driven by the patient’s medical needs, not by physician concerns about their status, expectations, or perceptions.

28/05/2026

A high intake of widely used preservative food additives is associated with increased risks of developing hypertension and cardiovascular disease.

14/05/2026

Polycystic o***y syndrome (PCOS) is estimated to affect over 170 million women worldwide during their reproductive years alone.

Recently, experts have agreed on a new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), to reflects the condition’s wide-ranging endocrine and metabolic features, and to help reduce misunderstandings about the disease. Find out more ▶️ http://spkl.io/6189ACRxB

👇 Panel: Context and the case for a new name.

13/05/2026

About 20 years ago, neuropathologists began to report an inconvenient finding in the autopsied brains of people with dementia: Most have evidence of more than one disease. Studies since have shown the brains of up to half of people diagnosed with Alzheimer’s disease also have a key feature of Parkinson’s disease—deposits of the protein alpha synuclein. At the same time, up to half of Parkinson’s patients who develop dementia have elevated levels of beta amyloid and tau proteins, hallmarks of Alzheimer’s.

Researchers studying neurodegenerative diseases are catching on to the importance of this phenomenon, often called copathology.

Tests now being developed to pick up multiple biomarkers should give a clearer picture of these mixed pathologies in living patients. And an upcoming clinical trial will be the first to take aim at a common dementia copathology, testing the amyloid-clearing Alzheimer’s drug donanemab in people who have both amyloid in their brains and dementia with Lewy bodies—abnormal clumps of alpha synuclein.

Learn more: https://scim.ag/4ujMAkn

12/05/2026

Brilliant Nuanced Article

A Columbia researcher argues that everything from stress to aging comes down to how energy moves through your body.

04/05/2026

Absolutely EXCELLENT review

A Review in Communications Medicine explores Long COVID — which affects more than 400 million people globally — including current knowledge, gaps and future directions for research, diagnosis and treatment.

Link to the article in the comments.

04/05/2026

Type 2 is a condition of elevated blood glucose levels that may cause serious health consequences including vision loss, heart disease, stroke, nerve damage, and kidney failure.

📄 Learn more in this JAMA Patient Page.

https://ja.ma/4tSM5xE

04/05/2026

02/05/2026

Now online! An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut: Enterotoxigenic Bacteroides fragilis (ETBF), a classically anaerobic pathogen, uses its toxin, BFT, to remodel host metabolism and generate a localized oxidative niche in the colon. By shifting epithelial cells toward fermentative metabolism, ETBF increases lactate and oxygen availability, allowing this anaerobe to deploy oxidative metabolism to adapt to and thrive in the inflamed gut.

http://dlvr.it/TSLC1z